Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ter Arkh ; 85(12): 41-6, 2013.
Artigo em Russo | MEDLINE | ID: mdl-24640666

RESUMO

AIM: To evaluate the clinical efficiency, tolerance, and pharmacoeconomic parameters of treatment for mild community-acquired pneumonia (CAP) in patients with risk factors for ineffective treatment with levofloxacin (Glevo) versus original levofloxacin and standard pharmacotherapy regimens for mild pneumonia (real practice). SUBJECTS AND METHODS: An open-label comparative randomized trial was conducted in parallel groups of 147 patients aged > or = 18 years with mild CAP and risk factors for ineffective treatment. Group 1 included 61 patients (59 men and 2 women; mean age 23.3 +/- 11.2 years) receiving levofloxacin (Glevo) 500 mg/day; Group 2 comprised 41 patients (39 men and 1 woman; mean age 26.4 +/- 13.4 years) treated with original levofloxacin 500 mg/day; Group 3 consisted of 45 patients (all men; mean age 23.7 +/- 9.9 years) on standard therapy. The trial was performed in 3 pulmonology centers. RESULTS: The use of the respiratory fluoroquinolone levofloxacinto treat mild CAP in the patients with risk factors for failure for its therapy demonstrated a higher efficiency than the antibiotic regimens used in real clinical practice. This suggests that physicians underestimate risk factors and do not always make a rational choice of an antimicrobial agent in the given clinical situation. CONCLUSION: The generic form of levofloxacin (Glevo) is as clinically effective as its original drug in the treatment of CAP and characterized by its optimal pharmacoeconomic parameters.


Assuntos
Antibacterianos/administração & dosagem , Infecções Comunitárias Adquiridas/tratamento farmacológico , Levofloxacino/administração & dosagem , Pneumonia/tratamento farmacológico , Adolescente , Adulto , Antibacterianos/efeitos adversos , Antibacterianos/economia , Feminino , Humanos , Levofloxacino/efeitos adversos , Levofloxacino/economia , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Índice de Gravidade de Doença , Resultado do Tratamento , Adulto Jovem
3.
Vestn Khir Im I I Grek ; 121(10): 88-9, 1978 Oct.
Artigo em Russo | MEDLINE | ID: mdl-716151

RESUMO

Clinical observation over 61 cases of acute anorectal thrombosis and thrombophlebitis was carried out. The duration of the disease ranged from some months to 35 years. The clinical observations have proved the advantages of laserotherapy over phototherapy with monochromatic incoherent red light and its high therapeutic activity in acute anorectal thrombosis and thrombophlebitis.


Assuntos
Hemorroidas/complicações , Terapia a Laser , Tromboflebite/cirurgia , Trombose/cirurgia , Doença Crônica , Seguimentos , Hélio , Hemorroidas/cirurgia , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...